Who owns the ISTERIAN trademark?

The ISTERIAN trademark is owned by Cambrian BioPharma, Inc..

What class is the ISTERIAN trademark registered in?

The ISTERIAN trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ISTERIAN?

The USPTO serial number for ISTERIAN is 97705569.

What is the registration number for ISTERIAN?

ISTERIAN is registered under USPTO registration number 7739812.

Sealvo

Home Search: ISTERIANISTERIAN #97705569

Back

Updated Sep 19, 2026·11 searches this week

View on USPTO TSDR Find similar marks

IST

USPTO Trademark Record

REGISTERED

ISTERIAN

SN 97705569·Reg 7739812·Filed Dec 06, 2022

Owner Cambrian BioPharma, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ISTERIAN (Serial No. 97705569), Registration No. 7739812, is a registered US trademark filed on Dec 06, 2022 by Cambrian BioPharma, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 25, 2031

Conflict Analysis

Full conflict analysis for ISTERIAN (SN 97705569) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

ISTERIAN (Reg. #7739812) is a registered US trademark that has been protecting its owner, Cambrian BioPharma, Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 06, 2022

SERIAL

97705569

REG#

7739812

REGISTERED

Mar 25, 2025

Filing Information

StatusREGISTERED

Filing DateDec 06, 2022

Serial Number97705569

Registration No.7739812

Registration DateMar 25, 2025

Status DateMar 25, 2025

Published for OppositionMay 07, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 21, 2024

First use in commerce: Nov 21, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

31 events

REGISTERED-PRINCIPAL REGISTER

Mar 25, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 25, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 05, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 05, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Feb 21, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 20, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 09, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 09, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 02, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 07, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 07, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 17, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 01, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 27, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 27, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 29, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NON-FINAL ACTION E-MAILED

Nov 29, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 29, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 29, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 29, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NON-FINAL ACTION WRITTEN

Nov 29, 2023

NON-FINAL ACTION WRITTEN

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 05, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 05, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 05, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jul 10, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 10, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 10, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jul 07, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 04, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 09, 2022

NEW APPLICATION ENTERED

Other Marks by Cambrian BioPharma, Inc.

Additional USPTO filings from the same owner.

OVI

OVIVA THERAPEUTICS

97603698

Cambrian BioPharma, Inc.

REGISTERED

TOR

TORNADO THERAPEUTICS

97978187

Cambrian BioPharma, Inc.

REGISTERED

TOR

TORNADO

97978188

Cambrian BioPharma, Inc.

REGISTERED

CAM

CAMBRIAN

97039174

Cambrian BioPharma, Inc.

REGISTERED

Other Marks by Matthew D. Delaney

Additional USPTO filings handled by the same attorney of record.

TAS

TASK TITANS VR

98914997

REGISTERED

MAM

MAMA CERTIFIED EQUITY CENTERED MATERNAL CARE

99389225

REGISTERED

FUN

FUN FOOD AUTHORITY

98805404

REGISTERED

GIG

GIGFLEX

88563758

REGISTERED

ISTERIAN

Run a conflict check

Other Marks by Cambrian BioPharma, Inc.

Other Marks by Matthew D. Delaney

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company